Healthcare
Live Price
Offline$5.43
+4.02% today
1Y Change
-0.57%
Window
Jun 27, 2025 → Jun 24, 2026
Coverage: 248 bars · Jun 27, 2025 → Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Myriad Genetics, Inc. (MYGN) is a Healthcare stock with a market cap of $450.00M and listed on NASDAQ. The stock last traded around $5.43 and down 0.6% across the available one-year price window (Jun 27, 2025 → Jun 24, 2026). Baseline metrics include revenue growth of -1.6%, EPS growth of -180.9%, a dividend yield of 0.0%. What stands out right now is revenue -1.6%, EPS -180.9%, free cash flow +104.7% with operating margin -31.7% and ROIC -41.8%. Valuation is more restrained than many high-expectation growth names at price/sales 0.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines MYGN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
MYGN
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
MYGN Max Drawdown
-56.60%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for MYGN and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
| Ex-Date | Record | Pay | Dividend | Adj | Frequency |
|---|---|---|---|---|---|
| Jul 1, 2009 | — | — | $1.75 | $1.75 | Monthly |
| Jun 15, 2009 | — | — | $1.75 | $1.75 | Monthly |
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.